Skip to main content
Equibles
KRYS logo

KRYS · Krystal Biotech, Inc. · Metrics

Track KRYS — free

Use KRYS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research KRYS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$347.00 +1.45 (+0.42%) At close · Sep 11
S&P 400 member Russell 2000 member Rebalance outlook locked
Market Cap
$10.23B
Shares
29.60M

KRYS metrics

73 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$347.00
Market cap
$10.23B

Price action

20 metrics
Price change (1W)
-7.0%
Price change (30D)
+5.2%
Price change (3M)
+7.5%
Price change (6M)
+37.5%
Price change (YTD)
+40.2%
Price change (1Y)
+151.4%
Trailing year
Price change (5Y)
+495.8%
52-week high
$378.15
52-week low
$137.46
Change from 52-week high
-8.6%
Change from 52-week low
+151.4%
Annualized volatility
39.1%
Annualized volatility (3M)
43.4%
Beta
0.8
RSI (14D)
47.8
Price vs SMA 50
-0.8%
Price vs SMA 200
+18.1%
Avg volume (3M)
408,405
Relative volume
0.4
Average dollar volume
$140.46M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
29.60M

Valuation

12 metrics
P / E (TTM)
43.4
Trailing earnings · reciprocal yield 2.3%
PEG ratio
1.1
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
23.2×
reciprocal yield 4.3%
P / book
7.5
reciprocal yield 13.3%
FCF yield
2.5%
TTM · current market cap
Buyback yield
—
P / FCF
39.7
reciprocal yield 2.5%
P / operating cash flow
37.6
reciprocal yield 2.7%
Earnings yield
2.4%

Historical valuation

8 metrics
P / E historical average (3Y)
38.4×
reciprocal yield 2.6%
P / E historical average (5Y)
38.4×
reciprocal yield 2.6%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-03

Profitability

9 metrics
Gross margin
—
Operating margin
44.9%
Trailing 12 months
Net margin
54.8%
Gross profit (TTM)
—
Operating profit (TTM)
$197.75M
Net income (TTM)
$241.47M
Trailing 12 months
Diluted EPS (TTM)
$7.97
FCF margin
58.5%
Effective tax rate
-6.6%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$41.78

Growth

11 metrics
Revenue growth YoY
+24.1%
Year over year
Net income growth YoY
+42.9%
Revenue (TTM)
$440.48M
Trailing 12 months
EPS growth YoY
+38.8%
Shares change YoY
+3.1%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
17.8%
Return on assets
16.1%
Debt / equity
—
Current ratio
8.3
EBITDA (TTM)
−$143.98M
Free cash flow (TTM)
$257.78M
Quick ratio
8.0
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$427.74M
Total assets
$1.50B
Total debt
$4.25M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$272.34M
Capital expenditures (TTM)
$14.56M
R&D (TTM)
$59.23M
SG&A (TTM)
$159.89M
Stock compensation (TTM)
$54.68M
R&D / revenue
13.4%
Stock compensation / revenue
12.4%

Ownership (13F)

3 metrics
13F filers
427
13F filer change QoQ
+55
Institutional ownership
103.9%

Short interest

3 metrics
Short interest
11.3%
Latest settlement · 15.3 days to cover
Days to cover
15.3d
Short-squeeze score
81 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$26.54M
Insider-sentiment score
28 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1711279 CUSIP 501147102 13F (30d) 161 filings 160 filers Visit website Investor relations